Home / Pharmaceutical company intelligence
Martin Dow Limited site mark
Pharmaceutical company intelligence

Martin Dow products and prices in Pakistan

Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.

Follow price changes 🔒 Company report (Pharma Pro)

Pharmaceutical manufacturer · Karachi · Pakistan

Core pharmaceutical entity of the Martin Dow Group, manufacturing and marketing branded generics and research-based products in Pakistan.

Martin Dow products in Pakistan

Martin Dow Limited has 237 medicine presentations registered in Pakistan under 70 brands, covering 61 generic medicines. Most of its products are in Anti-infectives, CNS & mental health and Endocrine & metabolic. Its brands with the most registered strengths and packs are Empator-M (Empagliflozin + Metformin), Elicia (Levetiracetam), Dowtel-AM (Telmisartan + Amlodipine) and Meblot (Ibuprofen). 237 products have an official DRAP price on MedInfoBase. See all 70 brands A to Z

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation10 Nov 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check12 Oct 2026Latest source-check date across this published portfolio
Latest effective price date27 Jul 2026Newest effective date among published current price records
Corporate profile evidence4 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Company type
Pharmaceutical manufacturer
Address
Nice Trade Orbit Building, Plot No. 44-A & B, PECHS Block VI, Shahrah-e-Faisal, Karachi, Pakistan
Phone
+92 21 111 111 634
Official contact
Contact page ↗
Corporate source details checked
16 Aug 2026
Corporate profile completeness
88%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000267 Martin Dow Ltd. · Sindh
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000267 237 linked products · source seen 10 Nov 2026 View source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx261public portfolio records represented
REG180unique registrations represented
IDX237indexed MedInfoBase presentations
SRC0additional source-observed presentations
R+24registry-only registrations
VER103registry-verified exact registrations
PKR237current validated price records
G61generic molecules in indexed catalogue
DF8dosage-form groups
TA12therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage91%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage100%
priced packs safely normalized per unit
Comparable-market coverage95%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixMartin Dow LimitedShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/martin-dow-limitedGenerated 10 Nov 2026Anti-infectives77 · 32%CNS & mental health38 · 16%Endocrine & metabolic37 · 16%Cardiovascular25 · 11%Oncology & immunology15 · 6%Hematology & thrombosis12 · 5%Pain & musculoskeletal11 · 5%Other therapeutic areas22 · 9%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioMartin Dow LimitedDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/martin-dow-limitedGenerated 10 Nov 2026237presentationsTablet171 · 72%Injection20 · 8%Suspension15 · 6%Capsule14 · 6%Syrup7 · 3%Solution5 · 2%Other forms5 · 2%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionMartin Dow LimitedCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/martin-dow-limitedGenerated 10 Nov 2026225comparable productsBelow peer median51 · 23%Near peer median71 · 32%Above peer median103 · 46%Company median price position+3.5%Lowest-price equivalents2Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsMartin Dow LimitedCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/martin-dow-limitedGenerated 10 Nov 2026M/s. Genix Pharma (Pvt) Ltd.38 shared62% overlapMacter International Limited38 shared62% overlapNabiqasim Industries (Pvt) Ltd.,35 shared57% overlapCCL Pharmaceuticals (Pvt.) Limited34 shared56% overlapHIGH-Q Pharmaceuticals34 shared56% overlapWerrick Pharmaceuticals32 shared52% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Formulation footprint

Dosage forms

Tablet171 products
Injection20 products
Suspension15 products
Capsule14 products
Syrup7 products
Solution5 products
Inhalation3 products
Infusion2 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
🔒
MedInfoBase Pharma Pro

See where Martin Dow Limited is priced against the market

225 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.

Below / near / above medianCompany price positionProduct examplesExcel, PDF & PowerPoint
Unlock with Pharma Pro
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock

Regulatory & price activity

Observed database signals

Indexed registration numbers156Distinct registrations among indexed, published, presentation-validated products only
Verified price observations237
Products with a verified price237
Products with multiple price observations0
Source records with multiple versions236
Latest portfolio source check12 Oct 2026
Latest effective price date27 Jul 2026
Latest source observation10 Nov 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

180 unique registration(s) · 237 indexed presentation(s) · 24 registry-only registration(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
ABICLOT Clopidogrel 75 mg Tablet 10's 033843 PKR 293.14 PKR 29.31/tablet 🔒 Pharma Pro
ABICLOT PLUS Clopidogrel + Aspirin 75 mg + 75 mg Tablet 10's 046050 PKR 281.10 PKR 28.11/tablet 🔒 Pharma Pro
Acti KI Potassium iodide 130 mg Tablet 2*10's 107872 PKR 53.06 PKR 2.65/tablet 🔒 Pharma Pro
Amlesiv Amlodipine 5 mg Tablet 2x10's 120146 PKR 185.88 PKR 9.29/tablet 🔒 Pharma Pro
Amlesive Amlodipine 10 mg Tablet 2x10's 120147 PKR 299.48 PKR 14.97/tablet 🔒 Pharma Pro
Bactrim Sulfamethoxazole + Trimethoprim 400 mg + 80 mg Tablet 200's 003068 PKR 733.48 PKR 3.67/tablet 🔒 Pharma Pro
Bactrim Sulfamethoxazole + Trimethoprim 200 mg + 40 mg / 5 mL Syrup 50ml 003070 PKR 38.46 PKR 0.77/mL No comparator
Bactrim Forte Sulfamethoxazole + Trimethoprim 800 mg + 160 mg Tablet 100's 004172 PKR 563.21 PKR 5.63/tablet 🔒 Pharma Pro
Bactrim Forte Sulfamethoxazole + Trimethoprim 400 mg + 80 mg / 5 mL Syrup 50ml 014420 PKR 56.26 PKR 1.13/mL No comparator
Betamet Lotion 0.1%Registry verified Betamethasone Valerate ...... 1 mg — Lotion — 067930Official source ↗ No indexed price — —
Bilarig Tablet 20mgRegistry verified Bilastine — — — 129342Official source ↗ No indexed price — —
Caliana Clozapine 25 mg Tablet 5x10's 085688 PKR 1,595.79 PKR 31.92/tablet 🔒 Pharma Pro
Caliana Clozapine 100 mg Tablet 5x10's 085689 PKR 3,490.79 PKR 69.82/tablet 🔒 Pharma Pro
CAMDROVA Bisoprolol fumarate 5 mg Tablet 20's 057287 PKR 258.18 PKR 12.91/tablet 🔒 Pharma Pro
CAMDROVA Bisoprolol fumarate 10 mg Tablet 20's 057288 PKR 505.72 PKR 25.29/tablet 🔒 Pharma Pro
Cef-Midox Ceftazidime 250 mg Injection 1's 083726 PKR 167.85 PKR 167.85/vial/unit 🔒 Pharma Pro
Cef-Midox Ceftazidime 1000 mg IV/IM injection 1's 083793 PKR 479.56 PKR 479.56/vial/unit No comparator
Cef-Midox Ceftazidime 500 mg Injection 1's 083795 PKR 255.31 PKR 255.31/vial/unit 🔒 Pharma Pro
COLOSHYLD Lactulose 3.35 g/5 mL Syrup 60ml 049155 PKR 144.58 PKR 2.41/mL 🔒 Pharma Pro
COLOSHYLD Lactulose 3.35 g/5 mL Syrup 120ml 049155 PKR 293.28 PKR 2.44/mL 🔒 Pharma Pro
COLOSHYLD Lactulose 3.35 g/5 mL Syrup 240ml 049155 PKR 442.00 PKR 1.84/mL 🔒 Pharma Pro
Cyclorest Tablet 10mgRegistry verified cyclobenzaprine Hcl — — — 062796Official source ↗ No indexed price — —
DEFMAT Cephalexin 250 mg Capsule 12's 080641 PKR 213.08 PKR 17.76/capsule 🔒 Pharma Pro
DEFMAT Cephalexin 500 mg Capsule 12's 080642 PKR 426.55 PKR 35.55/capsule 🔒 Pharma Pro
DORMICUM Midazolam 7.5 mg Tablet 30's 011231 PKR 664.07 PKR 22.14/tablet 🔒 Pharma Pro
DORMICUM Midazolam 7.5 mg Tablet 10's 011231 PKR 230.58 PKR 23.06/tablet 🔒 Pharma Pro
DORMICUM Midazolam 7.5 mg Tablet 18's 011231 PKR 415.04 PKR 23.06/tablet 🔒 Pharma Pro
DORMICUM Midazolam 7.5 mg Tablet 20's 011231 PKR 451.92 PKR 22.60/tablet 🔒 Pharma Pro
Dow-D Ampoules ( / ) Cholecalciferol 5 mg/mL IM injection/oral solution 5's 122988 PKR 977.83 PKR 195.57/vial/unit No comparator
Dow-D Ampoules ( / ) Cholecalciferol 5 mg/mL IM injection/oral solution 1's 122988 PKR 230.30 PKR 230.30/vial/unit No comparator
Dowdacla Daclatasvir 30 mg Tablet 28's 090784 PKR 5,401.15 PKR 192.90/tablet 🔒 Pharma Pro
Dowdacla Daclatasvir 60 mg Tablet 28's 090785 PKR 9,022.64 PKR 322.24/tablet 🔒 Pharma Pro
DOWMOXI Moxifloxacin 400 mg Tablet 5's 064836 PKR 994.59 PKR 198.92/tablet 🔒 Pharma Pro
DOWPHAGE Metformin 850 mg Tablet 50's 049236 PKR 160.43 PKR 3.21/tablet 🔒 Pharma Pro
DOWPHAGE Metformin 850 mg Tablet 30's 049236 PKR 96.27 PKR 3.21/tablet 🔒 Pharma Pro
DOWPHAGE Metformin 500 mg Tablet 50's 049237 PKR 133.70 PKR 2.67/tablet 🔒 Pharma Pro
DOWPHAGE Metformin 250 mg Tablet 60's 052630 PKR 101.61 PKR 1.69/tablet 🔒 Pharma Pro
DOWPHAGE Metformin 250 mg Tablet 30's 052630 PKR 53.49 PKR 1.78/tablet 🔒 Pharma Pro
DOWPHAGE Metformin 1 g Tablet 50's 052631 PKR 183.49 PKR 3.67/tablet 🔒 Pharma Pro
Dowphage ER Metformin 750 mg Tablet 30's 081128 PKR 138.43 PKR 4.61/tablet No comparator
Dowphage ER Metformin 1000 mg Tablet 50's 081129 PKR 194.07 PKR 3.88/tablet 🔒 Pharma Pro
Dowphage ER Metformin 500 mg Tablet 50's 081139 PKR 133.70 PKR 2.67/tablet 🔒 Pharma Pro
Dowtel-AM Telmisartan + Amlodipine 40 mg + 5 mg Tablet 14's 081113 PKR 735.79 PKR 52.56/tablet 🔒 Pharma Pro
Dowtel-AM Telmisartan + Amlodipine 80 mg + 10 mg Tablet 14's 081114 PKR 1,226.33 PKR 87.60/tablet 🔒 Pharma Pro
Dowtel-AM Telmisartan + Amlodipine 80 mg + 10 mg Tablet 10's 081114 PKR 874.41 PKR 87.44/tablet 🔒 Pharma Pro
Dowtel-AM Telmisartan + Amlodipine 40 mg + 10 mg Tablet 30's 082995 PKR 1,540.75 PKR 51.36/tablet 🔒 Pharma Pro
Dowtel-AM Telmisartan + Amlodipine 40 mg + 10 mg Tablet 10's 082995 PKR 558.21 PKR 55.82/tablet 🔒 Pharma Pro
Dowtel-AM Telmisartan + Amlodipine 40 mg + 10 mg Tablet 20's 082995 PKR 1,060.81 PKR 53.04/tablet 🔒 Pharma Pro
Dowtel-AM Telmisartan + Amlodipine 40 mg + 10 mg Tablet 2x7's 082995 PKR 781.50 PKR 55.82/tablet 🔒 Pharma Pro
Dowtel-AM Telmisartan + Amlodipine 80 mg + 5 mg Tablet 30's 082996 PKR 2,037.17 PKR 67.91/tablet 🔒 Pharma Pro
A to Z

All 70 Martin Dow brands in Pakistan

  • ABICLOT Clopidogrel · 75 mg tablet
  • ABICLOT PLUS Clopidogrel + Aspirin · 75 mg + 75 mg tablet
  • Acti KI Potassium iodide · 130 mg tablet
  • Amlesiv Amlodipine · 5 mg tablet
  • Amlesive Amlodipine · 10 mg tablet
  • Bactrim Sulfamethoxazole + Trimethoprim · 200 mg + 40 mg / 5 mL syrup, 400 mg + 80 mg tablet
  • Bactrim Forte Sulfamethoxazole + Trimethoprim · 400 mg + 80 mg / 5 mL syrup, 800 mg + 160 mg tablet
  • Caliana Clozapine · 100 mg tablet, 25 mg tablet
  • CAMDROVA Bisoprolol fumarate · 10 mg tablet, 5 mg tablet
  • Cef-Midox Ceftazidime · 1000 mg injection, 250 mg injection, 500 mg injection
  • COLOSHYLD Lactulose · 3.35 g/5 mL syrup
  • DEFMAT Cephalexin · 250 mg capsule, 500 mg capsule
  • DORMICUM Midazolam · 7.5 mg tablet
  • Dow-D Ampoules ( / ) Cholecalciferol · 5 mg/mL injection
  • Dowdacla Daclatasvir · 30 mg tablet, 60 mg tablet
  • DOWMOXI Moxifloxacin · 400 mg tablet
  • DOWPHAGE Metformin · 1 g tablet, 250 mg tablet, 500 mg tablet
  • Dowphage ER Metformin · 1000 mg tablet, 500 mg tablet, 750 mg tablet
  • Dowtel-AM Telmisartan + Amlodipine · 40 mg + 10 mg tablet, 40 mg + 5 mg tablet, 80 mg + 10 mg tablet
  • Dowvent Inhalation Ipratropium bromide · 0.025 % solution
  • Dowvir Sofosbuvir + Velpatasvir · 400 mg + 100 mg tablet
  • DOWZIN Zinc sulfate · 20 mg tablet
  • Dowzinc Zinc sulfate monohydrate · 20 mg tablet
  • Elicia Levetiracetam · 100 mg/mL solution, 1000 mg tablet, 250 mg tablet
  • ELICIA ER Levetiracetam · 500 mg tablet, 750 mg tablet
  • ELIXABAN Apixaban · 2.5 mg tablet, 5 mg tablet
  • EMPATOR Empagliflozin · 10 mg tablet, 25 mg tablet
  • Empator-M Empagliflozin + Metformin · 10 mg + 1000 mg tablet, 12.5 mg + 1000 mg tablet, 12.5 mg + 500 mg tablet
  • EUARIA Dihydroartemisinin + Piperaquine · 40 mg + 320 mg capsule, 40 mg + 320 mg tablet
  • FANSIDAR Sulfadoxine + Pyrimethamine · 500 mg + 25 mg tablet
  • FANSIDAR PLUS Artesunate + Sulfadoxine + Pyrimethamine · 50 mg + 500 mg + 25 mg tablet
  • FATRID Simvastatin · 10 mg tablet, 20 mg tablet, 40 mg tablet
  • Frolot Tenofovir disoproxil · 300 mg tablet
  • FUVELOX Levofloxacin · 250 mg tablet, 500 mg tablet, 750 mg tablet
  • Imadev s Imatinib · 100 mg tablet, 400 mg tablet
  • Ismo Isosorbide dinitrate · 20 mg tablet
  • Jython Linezolid · 100 mg/5 mL suspension, 200 mg/100 mL infusion, 400 mg tablet
  • KINLEC Azithromycin · 200 mg/5 mL suspension
  • Lebreta Letrozole · 2.5 mg tablet
  • LINESTA Ciprofloxacin · 250 mg tablet, 250 mg/5 mL suspension, 500 mg tablet
  • MABINAT Rivaroxaban · 10 mg tablet, 15 mg tablet, 20 mg tablet
  • MALCIFER Iron polymaltose complex · 100 mg tablet, 100 mg elemental iron tablet, 50 mg/5 mL syrup
  • MALCIFER-F Iron polymaltose complex + Folic acid · 100 mg + 0.35 mg tablet, 100 mg elemental iron + 0.35 mg folic acid tablet
  • Meblot Ibuprofen · 100 mg/5 mL suspension, 200 mg tablet, 200 mg/5 mL suspension
  • Miltocef Cefotaxime · 1 g injection, 250 mg injection, 500 mg injection
  • MOLTIQ Misoprostol · 100 mcg tablet, 200 mcg tablet
  • New-Fort Cefotaxime · 250 mg injection
  • New-Zone Ceftriaxone · 500 mg injection
  • Norpro Metronidazole · 200 mg/5 mL suspension, 400 mg tablet
  • Orzit Azithromycin · 250 mg tablet, 500 mg tablet
  • OZBIR Sofosbuvir · 400 mg tablet
  • Paclinab Paclitaxel · 100 mg injection
  • Qudow Quetiapine · 100 mg tablet, 200 mg tablet, 25 mg tablet
  • RIBUVIR Ribavirin · 400 mg tablet, 400 mg capsule, 500 mg tablet
  • Rivelime Lenalidomide · 10 mg capsule, 25 mg capsule
  • Rocephin Ceftriaxone · 1 g injection, 250 mg injection, 500 mg injection
  • SALVAJ Artemether + Lumefantrine · 20 mg + 120 mg tablet
  • SALVAJ DS Artemether + Lumefantrine · 40 mg + 240 mg tablet
  • SALVAJ EEZ Artemether + Lumefantrine · 80 mg + 480 mg tablet
  • SIEZIRA Divalproex sodium · 500 mg tablet
  • Spiridow Tiotropium · 18 mcg capsule, 18 mcg inhalation
  • Symbidow Budesonide + Formoterol · 200 mcg + 6 mcg inhalation, 400 mcg + 12 mcg inhalation
  • Tarsinib Erlotinib · 100 mg tablet, 150 mg tablet
  • Taztin Piperacillin + tazobactam · 2.25 g + 2 g injection, 4 g + 0.5 g injection
  • TRAUN Risperidone · 1 mg tablet, 2 mg tablet, 3 mg tablet
  • Valium Diazepam · 10 mg tablet, 2 mg tablet, 5 mg tablet
  • Velmon-H Telmisartan + Hydrochlorothiazide · 40 mg + 12.5 mg tablet, 80 mg + 12.5 mg tablet, 80 mg + 25 mg tablet
  • Veltezo Bortezomib · 3.5 mg injection
  • XALFOCIN Cefixime · 400 mg capsule
  • Xelcit Clarithromycin · 125 mg/5 mL suspension, 250 mg tablet, 250 mg/5 mL suspension
Questions

Martin Dow: common questions

How many products does Martin Dow have in Pakistan?

Martin Dow Limited has 237 registered medicine presentations in Pakistan, sold under 70 brands and covering 61 generic medicines.

What are the main brands of Martin Dow?

By number of registered strengths and packs, its largest brands are Empator-M (Empagliflozin + Metformin), Elicia (Levetiracetam), Dowtel-AM (Telmisartan + Amlodipine), Meblot (Ibuprofen) and RIBUVIR (Ribavirin). This is not a sales ranking.

Which therapy areas does Martin Dow cover?

The most products are in Anti-infectives (77), CNS & mental health (38), Endocrine & metabolic (37), Cardiovascular (25) and Oncology & immunology (15).

Where can I see Martin Dow medicine prices?

Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.

MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). Martin Dow Limited — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved November 10, 2026, from https://medinfobase.com/company/martin-dow-limited/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.

Medicine brands A–Z:ABCDEFGHIJKLMNOPQRSTUVWXYZ0-9